Abstract
Although rare, hemophilia is an expensive condition to manage. Because it is also complex to manage, caring for those affected within a hemophilia treatment center provides the best treatment outcomes. Additional clotting factor products are on the horizon that will hopefully continue to improve management of this condition.
Original language | English (US) |
---|---|
Pages (from-to) | 47-51 |
Number of pages | 5 |
Journal | Journal of Managed Care Medicine |
Volume | 17 |
Issue number | 1 |
State | Published - 2014 |